Cancer BiologybioRxivPreprint
A screen for combination therapies in BRAF/NRAS wild type melanoma identifies nilotinib plus MEK inhibitor as a synergistic combination
Marco Ranzani, Kristel Kemper, Magali Michaut…·David J. Adams
DOI 10.1101/195354
Author
Primary ORCID profile (0000-0003-0881-5477 · 5 papers)Unclaimed ORCID profile · follow to get notified of new preprints
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
1 paper
Recent·Most cited